Live
Home·Deals·Medical Technology·American Industrial Partners acquires Avanos Medical
SEO URLwww.firestrike.ai/deals/avanos-medical-american-industrial-partners-acquisition-2026
acquisitionAnnounced · Apr 16, 2026Medical TechnologySource · CredibleArticle · Factual
Avanos Medical
American Industrial Partners
Avanos Medical · American Industrial Partners

American Industrial Partners acquires Avanos Medical

David Najork
David Najork · Founding Software Engineer
Published · Updated · 1 min read
ShareXLinkedInEmail
Deal value
$1.27B
Target
Avanos Medical
Avanos Medical
NYSE: AVNS · Alpharetta, Georgia
Acquirer
American Industrial Partners
American Industrial Partners
Full Acquisition
Status
Pending

American Industrial Partners (AIP) has entered an agreement to acquire Avanos Medical for $1.27 billion. This acquisition allows AIP to broaden its portfolio in the medical technology sector, targeting healthcare products and services. Avanos Medical, based in Alpharetta, Georgia, is known for its medical devices used in pain management and chronic care.

The transaction, set at $1.27 billion, remains subject to regulatory approvals and customary closing conditions. Avanos, a publicly traded company, will transition into a privately held entity under AIP's ownership upon completion. The acquisition details are yet to specify whether Avanos' current management team will remain in place.

For American Industrial Partners, the acquisition adds to its strategy of investing in industrial companies with strong potential for growth and innovation. Avanos' suite of healthcare products complements AIP's existing operations and provides an avenue for expansion in a market expected to grow due to increasing demand for advanced medical solutions.

This move comes amidst a highly competitive medical technology landscape, where innovation and scale are essential for capturing market share. Avanos' integration into AIP could intensify competitive pressures on other mid-sized medtech firms striving for both technological advancement and market growth. Meanwhile, larger players in the sector may continue seeking strategic acquisitions to consolidate their positions.

Pending successful regulatory clearance, the completion of this acquisition will mark another significant investment by AIP in its pursuit of expanding its footprint in the healthcare sector. The focus now shifts to navigating the regulatory landscape and satisfying any remaining conditions to seal the transaction.

Deal timeline

Announced
Apr 16, 2026 · bioxconomy.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in Medical Technology with a reported deal value of $1.27B. Figures and status may change as sources update.

Sources: bioxconomy.com · Primary article · FireStrike proprietary index